• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

SAFETY FEATURES FOR MEDICINAL PRODUCTS FOR HUMAN USE QUESTIONS AND ANSWERS – VERSION 12

In less than two months, starting on 9 February 2019, many prescription medicinal products in Europe will have to carry the required safety features. Therefore, the list of Q&As on safety features is continuously revised and supplemented.

 

Version 12 der Safety Features for Medicinal Products for Human Use.

News & Trends

Procurar

Recentes

  • Advice on ‘end-of-year’ submission dates for type I variations in 2026
  • EMA UPDATE : COMPLIANCE with EU GMP Annex 22 and Artificial Intelligence Standards
  • FDA GUIDANCE DOCUMENT – E2B(R3) Electronic Transmission of Individual Case Safety Reports Implementation Guide — Data Elements and Message Specification;
  • The Council of the European Union has formally adopted the Pharmaceutical Package
  • Sponsor Guidance: New Safety Module on the Annual Safety Report
  • A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
  • Electronic Submission Template for Premarket Approval Applications (PMAs)
  • MDSAP Technical Review and Recognition Decision Procedure

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto